Impax Laboratories Granted Final Fda Approval for Generic Doryx 75mg and 100mg Tablets
M2 EquityBites › December 30, 2010
Linked as:
Summary
EQUITYBITES-(C)2010 M2 COMMUNICATIONS
Speciality pharmaceutical company Impax Laboratories Inc (Nasdaq:IPXL) announced on Wednesday that the US Food and Drug Administration (FDA) has granted final approval of its Abbreviated New Drug Application for the generic version of Doryx (doxycyline hyclate delayed-release) 75mg and 100mg tablets.See the full content of this document
Extract
Impax Laboratories Granted Final Fda Approval for Generic Doryx 75mg and 100mg Tablets
Impax said that it is preparing f...
See the full content of this document
Sponsored links
